Site Search
410 result(s) found for “ adaptive therapy”
-
Autologous Stem Cell Transplants and Emerging Cell Therapies for Treatment-Resistant Autoimmune Diseases
Learn how Moffitt Cancer Center uses autologous stem cell transplants and other emerging cellular therapies to address treatment-resistant autoimmune...
-
Moffitt Experts Present Latest Research in Transplantation and Cellular Therapies
The Tandem Meetings bring together research and health care professionals from around the world
-
Q&A: Understanding Intralesional and Infusional Therapies for Metastatic Melanoma
Dr. Matthew Perez discusses intralesional and infusional therapies for metastatic melanoma and when to refer patients to Moffitt Cancer Center.
-
22MA043N ACT: Targeting Myeloid-Derived Suppressor Cells (MDSCs) In Bladder Cancer to Enhance Efficacy of Adoptive Cell Therapy (ACT)
FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICEThe Innovation Dedicated to supporting patients every step of the way, with...
-
The World’s First T-cell Therapy for a Solid Tumor Cancer is Poised for Approval via Moffitt Partnership
Iovance’s investment is further proof that the Cellular Immunotherapy Program at Moffitt is a leading center for cell and gene therapy research
-
Moffitt’s Newest Partnership to Advance Cell Therapies for Solid Tumors
Strategic alliance with Turnstone Biologics Corp. focuses on tumor infiltrating lymphocyte therapies
-
Moffitt Cancer Center Is First Health System in Tampa Bay Area To Receive Proton Therapy System for Cancer Treatment
IBA’s Proteus®ONE, arriving in February, will be the most advanced in the Tampa Bay area
-
21MA044N Immunotherapy: Quantifying The Tumor-Immune Ecosystem in Non-Small Cell Lung Cancer (NSCLC) To Identify Clinical Biomarkers of Therapy Response
FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICEThe Innovation Dedicated to supporting patients every step of the way, with...
-
21MA045N CAR-T: Differential Alternative Splicing in Relapsed and Refractory Diffuse Large B-Cell Lymphoma Patients Receiving CAR-T Therapy
FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICEThe Innovation Dedicated to supporting patients every step of the way, with...
-
19MB057 13MB048 Diagnostic for Predicting Response to Therapies in Multiple Myeloma
Download PDFMultiple Myeloma (MM) is an incurable but treatable cancer, where patients are prescribed a combination of drugs in response to...